116 STAT[removed]PUBLIC LAW[removed]—NOV. 6, 2002 Public Law[removed]107th Congress

First Page		Document Content
Date: 2013-05-02 13:56:01 Pharmacology Pharmaceuticals policy Orphan Drug Act Orphan drug Food and Drug Administration Pharmaceutical industry Rare disease Pharmaceutical drug National Organization for Rare Disorders Health Pharmaceutical sciences Medicine		116 STAT[removed]PUBLIC LAW[removed]—NOV. 6, 2002 Public Law[removed]107th Congress Add to Reading List Source URL: www.gpo.gov Download Document from Source Website File Size: 341,02 KB Share Document on Facebook

	TOWARDS AN RDI CONFERENCE PROGRAM Lisa Phelps, MPH Director of Strategic Planning and Project Development National Organization for Rare Disorders (NORD) Member of the Council of RDI DocID: 1uYRx - View Document
	APPENDIX A DocID: 1ggRJ - View Document
	Rare Disease DayJoin MassBio, VHL Alliance, member companies, patient groups, patients and legislators to recognize Rare Disease Day. Friday, February 28th 11 a.m. DocID: 18xb0 - View Document
	TOGETHER WE ARE STRONG CAP THE CO-PAY ON SPECIALTY TIER MEDICINES Several states are considering legislation to tackle high cost-sharing for specialty and orphan medications. Currently, people with rare diseases are forc DocID: 105bx - View Document
	3086100169545001237615[removed]FOR IMMEDIATE RELEASE DocID: Z1vh - View Document